Literature DB >> 11287817

Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists.

T Tadano1, M Hozumi, N Satoh, R Oka, T Hishinuma, M Mizugaki, Y Arai, H Yasuhara, H Kinemuchi, F Niijima, O Nakagawasai, K Tan-no, K Kisara.   

Abstract

Intraperitoneal injection of benzodiazepine receptor agonists (estazolam, zopiclone, triazolam: 0.03-0.24 mmol/kg) induces the head twitch response (HTR). The present study was undertaken to examine the possible participation of the serotonergic system in the mechanism of head twitches induced by benzodiazepine receptor agonists (BZ-RAs). The HTR induced by BZ-RAs was suppressed by pretreatment with ketanserine (1 mg/kg, i.p.), a selective 5-HT(2) receptor antagonist. Pretreatment with fluoxetine (10 mg/kg, i.p.), a 5-HT reuptake inhibitor, and 8-hydroxy-2-(di-n-propylamino)tetralin, a 5-HT(1A) receptor agonist, also suppressed the HTR induced by BZ-RAs. These results suggest that the HTR induced by BZ-RAs may be the result of an activation of postsynaptic 5-HT(2) receptors, probably due to direct action. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287817     DOI: 10.1159/000056089

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Regulation of 5-HT2A/C receptors and DOI-induced behaviors by protein kinase Cgamma.

Authors:  Barbara J Bowers; Jill Miyamoto-Ditmon; Jeanne M Wehner
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

2.  Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2013-02-14       Impact factor: 4.530

Review 3.  Serotonergic hallucinogens as translational models relevant to schizophrenia.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-13       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.